1. Home
  2. VSH vs BLTE Comparison

VSH vs BLTE Comparison

Compare VSH & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • BLTE
  • Stock Information
  • Founded
  • VSH 1962
  • BLTE 2018
  • Country
  • VSH United States
  • BLTE United States
  • Employees
  • VSH N/A
  • BLTE N/A
  • Industry
  • VSH Electrical Products
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • BLTE Health Care
  • Exchange
  • VSH Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • VSH 2.3B
  • BLTE 2.1B
  • IPO Year
  • VSH N/A
  • BLTE 2022
  • Fundamental
  • Price
  • VSH $16.05
  • BLTE $79.26
  • Analyst Decision
  • VSH Hold
  • BLTE Strong Buy
  • Analyst Count
  • VSH 1
  • BLTE 4
  • Target Price
  • VSH $19.00
  • BLTE $96.00
  • AVG Volume (30 Days)
  • VSH 1.3M
  • BLTE 57.9K
  • Earning Date
  • VSH 11-05-2025
  • BLTE 11-11-2025
  • Dividend Yield
  • VSH 2.49%
  • BLTE N/A
  • EPS Growth
  • VSH N/A
  • BLTE N/A
  • EPS
  • VSH N/A
  • BLTE N/A
  • Revenue
  • VSH $2,927,555,000.00
  • BLTE N/A
  • Revenue This Year
  • VSH $4.51
  • BLTE N/A
  • Revenue Next Year
  • VSH $7.04
  • BLTE N/A
  • P/E Ratio
  • VSH N/A
  • BLTE N/A
  • Revenue Growth
  • VSH N/A
  • BLTE N/A
  • 52 Week Low
  • VSH $10.35
  • BLTE $49.00
  • 52 Week High
  • VSH $20.15
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • VSH 54.95
  • BLTE 69.65
  • Support Level
  • VSH $14.75
  • BLTE $76.50
  • Resistance Level
  • VSH $16.16
  • BLTE $80.19
  • Average True Range (ATR)
  • VSH 0.60
  • BLTE 2.27
  • MACD
  • VSH 0.04
  • BLTE 0.43
  • Stochastic Oscillator
  • VSH 70.98
  • BLTE 92.28

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: